ClinicalTrials.gg
Sign In
Not yet recruitingNCT06736886Updated Dec 17, 2024

Effect of Light Color Temperature Applied During Breastfeeding on Mother's Stress, Anxiety, Peace and Breastfeeding Motivation

An interventional study of Light application in Light, Stress and Anxiety, sponsored by Osmaniye Korkut Ata University. Not yet recruiting. Open to female participants aged 18 Hours to 45 Hours, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-17.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Osmaniye Korkut Ata University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Hours to 45 Hours
Sex
Female
01

Study summary

Breastfeeding is an important condition for the health of the mother and the baby, which is the most difficult for mothers after birth. Since it is an important practice for both the mother and the baby, the evaluation and reduction of the mother's stress factors can help the hospital to regulate the lighting of the breastfeeding room. In addition, setting the light color temperature to a more appropriate kelvin can make a positive contribution to the hospital in terms of costs. For this purpose, when researchers look at the literature, we have not come across a randomized controlled study examining the effect of the light color temperature applied during breastfeeding on the mother's stress, anxiety, peace and breastfeeding motivation. Researchers' purpose is to determine the effect of the light color temperature applied during breastfeeding on the mother's stress, anxiety, peace and breastfeeding motivation.

02

Conditions studied

  • Light
  • Stress
  • Anxiety

Browse trials for

03

In context

Anxiety Disorders Unverified

7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's planned enrollment of 100 is above the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Osmaniye Korkut Ata University is the lead sponsor of 35 studies on the registry; 7 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Hours to 45 Hours
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mothers who have given birth for the first time,
  • being 18 years of age and older,
  • volunteering.

Exclusion criteria

Exclusion Criteria:

  • Being a mother who has given birth to more than one child,
  • having any problem that prevents communication (such as not knowing Turkish, having hearing, speaking and understanding disorders),
  • receiving psychiatric treatment (pharmacotherapy or psychotherapy),
  • having a disease that prevents vision.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Light application

    Other: Light application

  • Placebo comparator
    control group

    Light application

    Other: Light application

Interventions

  • OtherLight application

    Light application

06

What researchers measure

Primary outcomes

  1. stress scale

    QUESTIONNAIRE

    Time frame: 2 minutes

  2. anxiety scale

    QUESTIONNAIRE

    Time frame: 2 minutes

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Can be shared when necessary

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2024; primary completion for Dec 2024, 0 months later.

Of 3,836 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 0 months is below that.

Counting every sponsor, half of 3,938 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2024
First posted
Dec 17, 2024
StartEst.
Dec 25, 2024
Primary completionEst.
Dec 30, 2024
CompletionEst.
Jan 15, 2025
Last update
Dec 17, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06736886
Lead sponsor
Osmaniye Korkut Ata University
Responsible party
Emine Yıldırım (Assistant professor, Osmaniye Korkut Ata University) — Principal investigator
First posted
Dec 17, 2024
Start date
Dec 25, 2024 (estimated)
Primary completion
Dec 30, 2024 (estimated)
Completion
Jan 15, 2025 (estimated)
Last update
Dec 17, 2024

Study contacts

Emine Yıldırım, Assistant Professor
Contact
eminekucukyildirim@gmail.com
05066268672
Emine Yıldırım
Contact
emineyildirim@osmaniye.edu.tr
05066268672

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Anxiety Disorders →

Other studies from this sponsor

Osmaniye Korkut Ata University

Start the discussion